The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients
Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery...
Saved in:
Published in | Cardiovascular diabetology Vol. 13; no. 1; p. 52 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
24.02.2014
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.
The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.
Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.
As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus. |
---|---|
AbstractList | Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.
The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.
Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.
As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus. BACKGROUND: Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes. METHODS: The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels. RESULTS: Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c. CONCLUSION: As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus. Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.BACKGROUNDHypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in calcification of cartilage and vasculature. The goal of this study was to determine the relationship between serum HIF-1α with coronary artery calcification (CAC) in patients with type 2 diabetes.The subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.METHODSThe subjects were 405 (262 males, 143 females, age 51.3 ± 6.4 years) asymptomatic patients with type 2 diabetes mellitus. Serum HIF-1α and interleukin-6 (IL-6) levels were measured by ELISA. CAC scores were assessed by a 320-slice CT scanner. The subjects were divided into 4 quartiles depending on serum HIF-1α levels.Average serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.RESULTSAverage serum HIF-1α was 184.4 ± 66.7 pg/ml. Among patients with higher CAC scores, HIF-1α levels were also significantly increased (p <0.001). HIF-1α levels positively correlated with CRP, IL-6, UKPDS risk score, HbA1c, FBG, and CACS, but did not correlate with diabetes duration, age, and LDL. According to the multivariate analysis, HIF-1α levels significantly and independently predict the presence of CAC. ROC curve analysis showed that the serum HIF-1α level can predict the extent of CAC, but the specificity was lower than the traditional risk factors UKPDS and HbA1c.As a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus.CONCLUSIONAs a marker of hypoxia, serum HIF-1α level may be an independent risk factor for the presence of CAC. These findings indicate that elevated serum HIF-1α may be involved in vascular calcification in patients with type 2 diabetes mellitus. |
Author | Yang, Jian-hong Tang, Zhong-zhi Ai, Rong Li, Gang Chen, Fang Lu, Wei-hua |
AuthorAffiliation | 1 Emergency Department, Wuhan General Hospital of Guangzhou Military Command, Wu Luo Road, Hong Shan, Wuhan, China 3 Department of Medicine Laboratory, Wuhan General Hospital of Guangzhou Military Command, Wuhan, China 2 College of Foreign Language, Huazhong Agriculture University, Hongshan, Wuhan, Hubei 430070, China |
AuthorAffiliation_xml | – name: 2 College of Foreign Language, Huazhong Agriculture University, Hongshan, Wuhan, Hubei 430070, China – name: 1 Emergency Department, Wuhan General Hospital of Guangzhou Military Command, Wu Luo Road, Hong Shan, Wuhan, China – name: 3 Department of Medicine Laboratory, Wuhan General Hospital of Guangzhou Military Command, Wuhan, China |
Author_xml | – sequence: 1 givenname: Gang surname: Li fullname: Li, Gang – sequence: 2 givenname: Wei-hua surname: Lu fullname: Lu, Wei-hua – sequence: 3 givenname: Rong surname: Ai fullname: Ai, Rong – sequence: 4 givenname: Jian-hong surname: Yang fullname: Yang, Jian-hong – sequence: 5 givenname: Fang surname: Chen fullname: Chen, Fang – sequence: 6 givenname: Zhong-zhi surname: Tang fullname: Tang, Zhong-zhi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24564828$$D View this record in MEDLINE/PubMed |
BookMark | eNp1Ustu1TAUtFARfcCaHfKSTWgcP2JvkKDiJVViU9aW7ZxwjRI72A5wf4D_6Y_0m3B7y1WL6OrYc-bMHGt8jA5CDIDQc9K-IkSKU8J63nSStQ2hDe8eoaM9cnDnfIiOc_7WtqSXgjxBhx3jgslOHqHfFxvACSZTfAx54xdsofwECDhDWme82S7xlzeND8PqvJ0Aj8aVmDC5usQmDNjFFINJW2xSgVqcmZwfvbsRxD5gk7fzUuJcAYfLdgHc4cGbalPvS0UhlPwUPR7NlOHZbT1BX96_uzj72Jx__vDp7M15YxnvSjOIUfRCWsqcoFKo1jjG2MApB0vpyKQUDpgSoKSSBGxrmTDG9VQNhitp6Al6vdNdVjvD4Kp3MpNekp_rG3Q0Xt_vBL_RX-MPTRWVqudV4O1OwPr4gMD9jouzvs5BX-egCdW8qyIvb7dI8fsKuejZZwfTZALENWvCW0Y47RSp1Bd3F94b_U2wEk53BJdizgnGPYVUu_pH_uPO_5lwvtzEVRf204NzfwCE_sQx |
CitedBy_id | crossref_primary_10_1161_ATVBAHA_119_312509 crossref_primary_10_3390_antiox11112183 crossref_primary_10_1007_s40620_022_01432_8 crossref_primary_10_1371_journal_pone_0301281 crossref_primary_10_1002_cbin_11811 crossref_primary_10_1080_15384101_2020_1788251 crossref_primary_10_1016_j_kint_2016_05_020 crossref_primary_10_1038_s41598_017_12833_2 crossref_primary_10_1038_s41598_024_79393_0 crossref_primary_10_3390_biom14121592 crossref_primary_10_3390_ijms18050950 crossref_primary_10_1210_clinem_dgad710 crossref_primary_10_1016_j_ijid_2017_05_010 crossref_primary_10_1080_17435390_2022_2083995 crossref_primary_10_1097_MD_0000000000033210 crossref_primary_10_1007_s00018_024_05486_8 crossref_primary_10_1186_s12872_015_0073_6 crossref_primary_10_1186_s12933_015_0221_4 crossref_primary_10_1007_s11102_021_01157_0 crossref_primary_10_1016_j_scib_2023_07_032 crossref_primary_10_1161_HYPERTENSIONAHA_121_18778 crossref_primary_10_18632_oncotarget_22467 crossref_primary_10_1016_j_cellsig_2021_110219 crossref_primary_10_1155_2021_6675548 crossref_primary_10_4236_jdm_2022_121007 crossref_primary_10_3390_antiox9100963 crossref_primary_10_1016_j_bone_2015_12_004 crossref_primary_10_1016_j_gene_2018_04_078 crossref_primary_10_1038_s41401_018_0055_1 crossref_primary_10_1177_0003319716662423 crossref_primary_10_1177_1708538120904297 crossref_primary_10_3390_nu15173749 crossref_primary_10_1186_s12933_015_0238_8 crossref_primary_10_3389_fphar_2024_1380326 crossref_primary_10_1093_ckj_sfac224 crossref_primary_10_1164_rccm_201512_2380OC |
Cites_doi | 10.2337/diabetes.49.9.1571 10.1007/s001250100001 10.1016/j.atherosclerosis.2013.01.018 10.1186/1475-2840-11-101 10.1159/000080086 10.1148/radiol.2273020369 10.1210/jc.2005-0991 10.1161/01.ATV.0000133194.94939.42 10.1371/journal.pone.0046562 10.1111/j.1525-139X.2007.00255.x 10.1148/radiol.2283021006 10.1007/PL00002027 10.1016/S0168-8227(01)00239-X 10.1381/0960892054222867 10.1161/CIRCULATIONAHA.110.974899 10.1124/mol.106.027029 10.7314/APJCP.2012.13.10.5143 10.1111/j.1600-0765.2012.01503.x 10.1006/cyto.1999.0533 10.1161/ATVBAHA.111.230904 10.1016/j.bone.2006.02.061 10.1128/MCB.00192-09 10.2337/db11-0174 10.1111/j.1600-0722.2008.00548.x 10.1017/S0029665109990206 10.1101/gad.180406.111 10.1038/ki.2008.644 10.1016/j.jcmg.2012.06.006 10.1097/01.ASN.0000145894.57533.C4 10.2337/dc11-0008 10.2337/diabetes.53.12.3226 10.1042/CS20000335 10.1056/NEJMra0910283 10.1161/ATVBAHA.111.233601 10.1002/bies.20254 10.7314/APJCP.2013.14.6.3851 10.1161/01.RES.0000249379.55535.21 10.1210/er.2003-0015 10.1016/j.atherosclerosis.2012.08.014 10.1007/s00125-011-2191-8 10.1186/1475-2840-12-161 10.1016/j.biocel.2004.08.012 |
ContentType | Journal Article |
Copyright | Copyright © 2014 Li et al.; licensee BioMed Central Ltd. 2014 Li et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: Copyright © 2014 Li et al.; licensee BioMed Central Ltd. 2014 Li et al.; licensee BioMed Central Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1186/1475-2840-13-52 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1475-2840 |
EndPage | 52 |
ExternalDocumentID | PMC3938975 oai_biomedcentral_com_1475_2840_13_52 24564828 10_1186_1475_2840_13_52 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 29B 2VQ 2WC 4.4 53G 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C1A C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF FRP NPM 7X8 PPXIY ABVAZ AFGXO AFNRJ 5PM PJZUB |
ID | FETCH-LOGICAL-b452t-d6f6768b34c638690ac444d535eb33f4886ce496e98981eb0b46aac739da598a3 |
IEDL.DBID | RBZ |
ISSN | 1475-2840 |
IngestDate | Thu Aug 21 14:06:15 EDT 2025 Wed May 22 07:13:23 EDT 2024 Fri Jul 11 08:40:10 EDT 2025 Thu Jan 02 22:18:48 EST 2025 Thu Apr 24 23:05:40 EDT 2025 Tue Jul 01 04:19:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b452t-d6f6768b34c638690ac444d535eb33f4886ce496e98981eb0b46aac739da598a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1186/1475-2840-13-52 |
PMID | 24564828 |
PQID | 1504153291 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3938975 biomedcentral_primary_oai_biomedcentral_com_1475_2840_13_52 proquest_miscellaneous_1504153291 pubmed_primary_24564828 crossref_primary_10_1186_1475_2840_13_52 crossref_citationtrail_10_1186_1475_2840_13_52 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-02-24 |
PublicationDateYYYYMMDD | 2014-02-24 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-24 day: 24 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Cardiovascular diabetology |
PublicationTitleAlternate | Cardiovasc Diabetol |
PublicationYear | 2014 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | 10.1186/1475-2840-13-52-B15 10.1186/1475-2840-13-52-B37 10.1186/1475-2840-13-52-B38 10.1186/1475-2840-13-52-B17 10.1186/1475-2840-13-52-B39 10.1186/1475-2840-13-52-B18 10.1186/1475-2840-13-52-B19 10.1186/1475-2840-13-52-B8 10.1186/1475-2840-13-52-B40 10.1186/1475-2840-13-52-B20 10.1186/1475-2840-13-52-B42 10.1186/1475-2840-13-52-B21 10.1186/1475-2840-13-52-B4 10.1186/1475-2840-13-52-B22 10.1186/1475-2840-13-52-B5 10.1186/1475-2840-13-52-B23 10.1186/1475-2840-13-52-B6 10.1186/1475-2840-13-52-B46 10.1186/1475-2840-13-52-B7 10.1186/1475-2840-13-52-B25 10.1186/1475-2840-13-52-B47 10.1186/1475-2840-13-52-B1 10.1186/1475-2840-13-52-B3 10.1186/1475-2840-13-52-B26 10.1186/1475-2840-13-52-B48 10.1186/1475-2840-13-52-B49 10.1186/1475-2840-13-52-B28 10.1186/1475-2840-13-52-B29 - 10.1186/1475-2840-13-52-B51 10.1186/1475-2840-13-52-B30 10.1186/1475-2840-13-52-B52 10.1186/1475-2840-13-52-B31 10.1186/1475-2840-13-52-B10 10.1186/1475-2840-13-52-B32 10.1186/1475-2840-13-52-B11 10.1186/1475-2840-13-52-B33 10.1186/1475-2840-13-52-B34 10.1186/1475-2840-13-52-B13 10.1186/1475-2840-13-52-B36 21757657 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e55-71 11378214 - Diabetes Res Clin Pract. 2001 Jul;53(1):55-61 16046581 - J Clin Endocrinol Metab. 2005 Oct;90(10):5841-7 16887934 - Mol Pharmacol. 2006 Nov;70(5):1469-80 24188692 - Cardiovasc Diabetol. 2013;12:161 22304911 - Cell. 2012 Feb 3;148(3):399-408 15954094 - Bioessays. 2005 Jul;27(7):708-16 15561954 - Diabetes. 2004 Dec;53(12):3226-32 15155384 - Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70 19698203 - Proc Nutr Soc. 2009 Nov;68(4):370-7 19145240 - Kidney Int. 2009 May;75(9):890-7 23058065 - JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9 23886195 - Asian Pac J Cancer Prev. 2013;14(6):3851-4 19546236 - Mol Cell Biol. 2009 Aug;29(16):4467-83 24134530 - Cardiovasc Diabetol. 2013;12:149 19210137 - Curr Med Res Opin. 2009 Jan;25(1):39-45 19066318 - Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E333-42 21918209 - Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2169-71 23411040 - Atherosclerosis. 2013 Apr;227(2):250-8 15579497 - J Am Soc Nephrol. 2004 Dec;15(12):2959-64 23049707 - PLoS One. 2012;7(10):e46562 12869688 - Radiology. 2003 Sep;228(3):826-33 10463582 - Cancer Res. 1999 Aug 15;59(16):3915-8 21614571 - Diabetologia. 2011 Aug;54(8):1946-56 22900680 - Cardiovasc Diabetol. 2012;11:101 17374082 - Semin Dial. 2007 Mar-Apr;20(2):103-9 15978153 - Obes Surg. 2005 Jun-Jul;15(6):813-9 15308873 - Am J Nephrol. 2004 Jul-Aug;24(4):415-21 12958148 - FASEB J. 2003 Nov;17(14):2115-7 18705802 - Eur J Oral Sci. 2008 Aug;116(4):341-52 10969842 - Diabetes. 2000 Sep;49(9):1571-8 12728184 - Radiology. 2003 Jun;227(3):795-801 11724655 - Clin Sci (Lond). 2001 Dec;101(6):671-9 15618010 - Int J Biochem Cell Biol. 2005 Mar;37(3):535-40 23078882 - Atherosclerosis. 2012 Dec;225(2):432-7 15294885 - Endocr Rev. 2004 Aug;25(4):629-72 12742296 - J Am Coll Cardiol. 2003 May 7;41(9):1547-53 11479936 - Herz. 2001 Jun;26(4):245-51 11719828 - Diabetologia. 2001 Nov;44(11):1973-88 21398528 - Diabetes Care. 2011 May;34(5):1219-24 21873554 - Diabetes. 2011 Oct;60(10):2484-95 10704252 - Cytokine. 2000 Mar;12(3):246-52 22302938 - Genes Dev. 2012 Feb 1;26(3):259-70 21163451 - JACC Cardiovasc Imaging. 2010 Dec;3(12):1229-36 22905750 - J Periodontal Res. 2013 Feb;48(1):52-65 21323543 - N Engl J Med. 2011 Feb 17;364(7):656-65 22498325 - JACC Cardiovasc Imaging. 2012 Apr;5(4):367-9 11698256 - Am J Physiol Cell Physiol. 2001 Dec;281(6):C1971-7 17095733 - Circ Res. 2006 Nov 10;99(10):1044-59 22144573 - Circulation. 2011 Dec 20;124(25):2855-64 16616713 - Bone. 2006 Sep;39(3):513-22 19691832 - BMC Med Genet. 2009;10:79 23244125 - Asian Pac J Cancer Prev. 2012;13(10):5143-8 |
References_xml | – ident: 10.1186/1475-2840-13-52-B15 doi: 10.2337/diabetes.49.9.1571 – ident: 10.1186/1475-2840-13-52-B29 doi: 10.1007/s001250100001 – ident: 10.1186/1475-2840-13-52-B25 doi: 10.1016/j.atherosclerosis.2013.01.018 – ident: 10.1186/1475-2840-13-52-B23 doi: 10.1186/1475-2840-11-101 – ident: 10.1186/1475-2840-13-52-B46 doi: 10.1159/000080086 – ident: 10.1186/1475-2840-13-52-B20 doi: 10.1148/radiol.2273020369 – ident: 10.1186/1475-2840-13-52-B34 doi: 10.1210/jc.2005-0991 – ident: 10.1186/1475-2840-13-52-B1 doi: 10.1161/01.ATV.0000133194.94939.42 – ident: 10.1186/1475-2840-13-52-B33 doi: 10.1371/journal.pone.0046562 – ident: 10.1186/1475-2840-13-52-B3 doi: 10.1111/j.1525-139X.2007.00255.x – ident: 10.1186/1475-2840-13-52-B21 doi: 10.1148/radiol.2283021006 – ident: 10.1186/1475-2840-13-52-B17 doi: 10.1007/PL00002027 – ident: - doi: 10.1016/S0168-8227(01)00239-X – ident: 10.1186/1475-2840-13-52-B49 doi: 10.1381/0960892054222867 – ident: 10.1186/1475-2840-13-52-B10 doi: 10.1161/CIRCULATIONAHA.110.974899 – ident: 10.1186/1475-2840-13-52-B28 doi: 10.1124/mol.106.027029 – ident: 10.1186/1475-2840-13-52-B37 doi: 10.7314/APJCP.2012.13.10.5143 – ident: 10.1186/1475-2840-13-52-B39 doi: 10.1111/j.1600-0765.2012.01503.x – ident: 10.1186/1475-2840-13-52-B42 doi: 10.1006/cyto.1999.0533 – ident: 10.1186/1475-2840-13-52-B7 doi: 10.1161/ATVBAHA.111.230904 – ident: - doi: 10.1016/j.bone.2006.02.061 – ident: 10.1186/1475-2840-13-52-B51 doi: 10.1128/MCB.00192-09 – ident: 10.1186/1475-2840-13-52-B32 doi: 10.2337/db11-0174 – ident: 10.1186/1475-2840-13-52-B40 doi: 10.1111/j.1600-0722.2008.00548.x – ident: 10.1186/1475-2840-13-52-B48 doi: 10.1017/S0029665109990206 – ident: 10.1186/1475-2840-13-52-B52 doi: 10.1101/gad.180406.111 – ident: 10.1186/1475-2840-13-52-B4 doi: 10.1038/ki.2008.644 – ident: - doi: 10.1016/j.jcmg.2012.06.006 – ident: 10.1186/1475-2840-13-52-B18 doi: 10.1097/01.ASN.0000145894.57533.C4 – ident: 10.1186/1475-2840-13-52-B13 doi: 10.2337/dc11-0008 – ident: 10.1186/1475-2840-13-52-B30 doi: 10.2337/diabetes.53.12.3226 – ident: 10.1186/1475-2840-13-52-B19 doi: 10.1042/CS20000335 – ident: 10.1186/1475-2840-13-52-B26 doi: 10.1056/NEJMra0910283 – ident: 10.1186/1475-2840-13-52-B8 doi: 10.1161/ATVBAHA.111.233601 – ident: 10.1186/1475-2840-13-52-B5 doi: 10.1002/bies.20254 – ident: 10.1186/1475-2840-13-52-B36 doi: 10.7314/APJCP.2013.14.6.3851 – ident: 10.1186/1475-2840-13-52-B6 doi: 10.1161/01.RES.0000249379.55535.21 – ident: 10.1186/1475-2840-13-52-B38 doi: 10.1210/er.2003-0015 – ident: 10.1186/1475-2840-13-52-B11 doi: 10.1016/j.atherosclerosis.2012.08.014 – ident: 10.1186/1475-2840-13-52-B31 doi: 10.1007/s00125-011-2191-8 – ident: 10.1186/1475-2840-13-52-B22 doi: 10.1186/1475-2840-12-161 – ident: 10.1186/1475-2840-13-52-B47 doi: 10.1016/j.biocel.2004.08.012 – reference: 21757657 - Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e55-71 – reference: 15155384 - Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1161-70 – reference: 10969842 - Diabetes. 2000 Sep;49(9):1571-8 – reference: 15954094 - Bioessays. 2005 Jul;27(7):708-16 – reference: 23078882 - Atherosclerosis. 2012 Dec;225(2):432-7 – reference: 19546236 - Mol Cell Biol. 2009 Aug;29(16):4467-83 – reference: 12958148 - FASEB J. 2003 Nov;17(14):2115-7 – reference: 17095733 - Circ Res. 2006 Nov 10;99(10):1044-59 – reference: 23058065 - JACC Cardiovasc Imaging. 2012 Oct;5(10):990-9 – reference: 19691832 - BMC Med Genet. 2009;10:79 – reference: 12869688 - Radiology. 2003 Sep;228(3):826-33 – reference: 11698256 - Am J Physiol Cell Physiol. 2001 Dec;281(6):C1971-7 – reference: 16616713 - Bone. 2006 Sep;39(3):513-22 – reference: 15579497 - J Am Soc Nephrol. 2004 Dec;15(12):2959-64 – reference: 19066318 - Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E333-42 – reference: 24134530 - Cardiovasc Diabetol. 2013;12:149 – reference: 16046581 - J Clin Endocrinol Metab. 2005 Oct;90(10):5841-7 – reference: 23049707 - PLoS One. 2012;7(10):e46562 – reference: 21163451 - JACC Cardiovasc Imaging. 2010 Dec;3(12):1229-36 – reference: 11724655 - Clin Sci (Lond). 2001 Dec;101(6):671-9 – reference: 19698203 - Proc Nutr Soc. 2009 Nov;68(4):370-7 – reference: 11719828 - Diabetologia. 2001 Nov;44(11):1973-88 – reference: 11378214 - Diabetes Res Clin Pract. 2001 Jul;53(1):55-61 – reference: 19210137 - Curr Med Res Opin. 2009 Jan;25(1):39-45 – reference: 16887934 - Mol Pharmacol. 2006 Nov;70(5):1469-80 – reference: 17374082 - Semin Dial. 2007 Mar-Apr;20(2):103-9 – reference: 21873554 - Diabetes. 2011 Oct;60(10):2484-95 – reference: 12728184 - Radiology. 2003 Jun;227(3):795-801 – reference: 19145240 - Kidney Int. 2009 May;75(9):890-7 – reference: 21398528 - Diabetes Care. 2011 May;34(5):1219-24 – reference: 23411040 - Atherosclerosis. 2013 Apr;227(2):250-8 – reference: 22144573 - Circulation. 2011 Dec 20;124(25):2855-64 – reference: 22900680 - Cardiovasc Diabetol. 2012;11:101 – reference: 22302938 - Genes Dev. 2012 Feb 1;26(3):259-70 – reference: 21323543 - N Engl J Med. 2011 Feb 17;364(7):656-65 – reference: 21918209 - Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2169-71 – reference: 15618010 - Int J Biochem Cell Biol. 2005 Mar;37(3):535-40 – reference: 15294885 - Endocr Rev. 2004 Aug;25(4):629-72 – reference: 21614571 - Diabetologia. 2011 Aug;54(8):1946-56 – reference: 11479936 - Herz. 2001 Jun;26(4):245-51 – reference: 15308873 - Am J Nephrol. 2004 Jul-Aug;24(4):415-21 – reference: 18705802 - Eur J Oral Sci. 2008 Aug;116(4):341-52 – reference: 23244125 - Asian Pac J Cancer Prev. 2012;13(10):5143-8 – reference: 24188692 - Cardiovasc Diabetol. 2013;12:161 – reference: 22498325 - JACC Cardiovasc Imaging. 2012 Apr;5(4):367-9 – reference: 22905750 - J Periodontal Res. 2013 Feb;48(1):52-65 – reference: 15978153 - Obes Surg. 2005 Jun-Jul;15(6):813-9 – reference: 23886195 - Asian Pac J Cancer Prev. 2013;14(6):3851-4 – reference: 10463582 - Cancer Res. 1999 Aug 15;59(16):3915-8 – reference: 15561954 - Diabetes. 2004 Dec;53(12):3226-32 – reference: 22304911 - Cell. 2012 Feb 3;148(3):399-408 – reference: 10704252 - Cytokine. 2000 Mar;12(3):246-52 – reference: 12742296 - J Am Coll Cardiol. 2003 May 7;41(9):1547-53 |
SSID | ssj0017861 |
Score | 2.248196 |
Snippet | Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is implicated in... BACKGROUND: Hypoxia-inducible factor 1 (HIF-1), a master regulator of oxygen homeostasis, is a heterodimer consisting of HIF-1α and HIF-1β subunits, and is... |
SourceID | pubmedcentral biomedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 52 |
SubjectTerms | Asymptomatic Diseases Biomarkers - blood Coronary Vessels - diagnostic imaging Coronary Vessels - metabolism Cross-Sectional Studies Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - diagnostic imaging Female Humans Hypoxia-Inducible Factor 1, alpha Subunit - blood Male Middle Aged Original Investigation Radiography Vascular Calcification - blood Vascular Calcification - diagnosis Vascular Calcification - diagnostic imaging |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bitRAEG10BfFFvO94owQffMk6nb6kg4iIuCzC-OTAvjXVSYcJzGbGucDmB_wff8RvsrqT7Bp3ffExdCpNUlXpOunKOYy9dqLSSLghccZjIh1qSqlKEeYxhZjmmOmoQzb7qk_m8supOr2UA-of4PZaaBf0pOab5dH59_YDJfz7mPBGv-UyUwm9ZqcJFzTJTXaLlqUsyBnM5OWWQmY077l9rjEKpMCBWcUEWfbRr-_L8Yp1pQz9u5vyj-Xp-B6729eV8LELhPvshm8esNuzfuf8IftB8QCbofNtUa-h79ACisH9GSza9eq8xoQg-r6o3dJDp8QD_NdPwKaEIlAd4KaF2ATaAvk2tvPFC0LdAG7bs_VuFSlgIXzZhRS6L7t03NO3bh-x-fHnb59Okl6DIXFSpbuk1JUmROKELChTCUpjIaUslVCEwkVF6a8LL3Ptgw4l927qpEYsMpGXqHKD4jE7aFaNP2SgZaUd8qx0aCQBJVQSqXhUymjBU19N2LvRc7frjm_DBgbs8Qglow0OtMGBlgur0gk7Grxki57ePKhsLG2EOUZfNXhzYTDM9M9TXw1ut5R9YUsFG7_aby2V01QBiTTnE_akC4OLiw3xNGHZKEBG9zUeaepFZPgWOdWRmXr635bP2B2q7GT8914-Zwe7zd6_oOpp517GrPgN83ocsQ priority: 102 providerName: Scholars Portal |
Title | The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24564828 https://www.proquest.com/docview/1504153291 http://dx.doi.org/10.1186/1475-2840-13-52 https://pubmed.ncbi.nlm.nih.gov/PMC3938975 |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NatwwEB6aBEovpf_ZtF1U6KEXtyvr1_TUlIRQ2FBKA0svQrJl1rDxLvsD3RfI-_RF-kwdyfa23rSnXgzG0hhrNNZ8mtE3AK8dK6VF3JA47W3CnZVoUqVAzKNzNsqskrEO2fhSXlzxTxMx-U0WvRfBp1q-o1yJBH-io4QyFHEARylHPBeA-em3XcBA6YYatWvcsvj8RcDeyfZZf0G65WXuJ0v-sfqcP4D7rdtIPjR6fgh3fP0I7o7bwPhjuEF1k2WX2DatFqRNwCI4xTbXZLpdzL9XNkEEvskrN_OkKbRD6M8fxNYFyQOTgV1uSczx3BJUXczWiwJJVRO72l4v1vPI8ErCxi1JSbNxi_ctO-vqCVydn339eJG0JRYSx0W6TgpZSgQcjvEcDRGRss0554VgAkE2K9G6Ze55Jn0oM0m9Gzkurc0VyworMm3ZUzis57U_BiJ5KZ2lqnBWc8RBVnCLvqEQWjKa-nIA73vjbhYNnYYJBNf9J2hrJmjNBK0ZyoxIB_C205LJW_byUERjZiKK0fJ2hze7Dt2b_tn0Vad2g8YVIia29vPNyqC3jA4OSzM6gGfNNNgJCxFjjnh1AKo3QXrf1X9SV9NI4M0ydBOVOPmvEXkO99B54_F4PX8Bh-vlxr9EB2nthnCgJmoIR6dnl5-_DOM2A17HXA-j0fwCWRET4A |
linkProvider | BioMedCentral |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIgGXimfZ8jISBy4pm_iRRJwAUS3Q7WkrVVysseNoI22zq31I7B_g__BH-E2MnWTVtHDiGCWxE8-MPZ898w3AG8NLhYQbIpM5jIRBRSZVSsI8meXDHFMV6pCNz9ToXHy9kBd7MOlyYWwvCrPZfwz7y8dX09FnYQ7vQscay8_Uu1ikMqL5dhjFnHq7BbdTKdOQ1fXx--5sIc0aFtXu4Zbw5y8NXEuCn_XXrhsO6fW4yisL1cl9OGg9TPah-ewHsOfqh3Bn3J6hP4KfpBls2cXATasFa2O1GGnj5pJNt4v5jwojAusbW5mZY01NHhb__sWwLpj1pAe43LIQDrplJOUQ2BcaZFXNcLW9XKzngQyW-T1elrBmjOm6JXJdPYbzk8-TT6OorcYQGSGTdVSoUhE2MVxYslkC1WiFEIXkkvA4L2kiUNaJXDlfkTJ2ZmiEQrQpzwuUeYb8CezX89o9BaZEqQzGaWEwEwSZUAokN1LKTPE4ceUA3vfGXS8a5g3tubD7d0gPtJea9lLTMdcyGcBxJyVtW6JzX29jpgPgydTNF97uXuh6-uejrzuxa7JDf7iCtZtvVpoca_KFeJLHAzhs1GDXmD9cFgRtB5D2FKT3X_07dTUNXN88J48ylUf_NSKv4O5oMj7Vp1_Ovj2De-TziZCVL57D_nq5cS_Ir1qbl8FM_gDeaiRE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VIlVcUHkvpWAkDlzSbuJXIk4tsCqPVgixUsXFsh1HG7HNRvuQ2D_A_-GP8Js6dpJV08KJW6L4oXhm7Pns8TcArwwthEbcEJnU6YgZLdCkCo6YJ7V0mGkpQh6y0zNxMmYfz_n5Foy7uzC2F4XZ7D-G_eWDq9fRp2EOxwf747DOi8b0U3EYM8kjnHCHUUyxu1twW3IufWKDr8ffN4cLMm1oVLvCLePPXxq4dgt-2l-8bnik1wMrr6xUo12427qY5KjRiXuw5ar7sHPaHqI_gF-oGmTeBcFNypq0wVoE1XF1QSbrevaz1BGi9ZUtzdSRJikPif_8JrrKifWsB3q-JiEedE1QzCGyLzRIyoroxfqiXs4CGyzxm7wkIc0g43vL5Lp4COPR-29vT6I2HUNkGE-WUS4KgeDEUGbRaBFVa8sYyznlCMhpgTOBsI5lwvmUlLEzQ8OE1lbSLNc8SzV9BNvVrHJPgAhWCKNjmRudMsRMmjONfiTnqaBx4ooBvOmNu6ob6g3lybD7X1ARlJea8lJTMVU8GcBBJyVlW6Zzn3BjqgLiScXNCq83Fbqe_ln0ZSd2hYboT1d05WarhULPGp0hmmTxAB43arBpzJ8uM8S2A5A9Ben9V_9LVU4C2TfN0KWU_Ol_jcgL2PnybqQ-fzj7tAd30Odj4VY-ewbby_nK7aNftTTPg5VcAlmoJA8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+relationship+between+serum+hypoxia-inducible+factor+1%CE%B1+and+coronary+artery+calcification+in+asymptomatic+type+2+diabetic+patients&rft.jtitle=Cardiovascular+diabetology&rft.au=Li%2C+Gang&rft.au=Lu%2C+Wei-hua&rft.au=Ai%2C+Rong&rft.au=Yang%2C+Jian-hong&rft.date=2014-02-24&rft.pub=BioMed+Central&rft.eissn=1475-2840&rft.volume=13&rft.spage=52&rft.epage=52&rft_id=info:doi/10.1186%2F1475-2840-13-52&rft_id=info%3Apmid%2F24564828&rft.externalDocID=PMC3938975 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon |